The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

Enormous progress has been made globally in the use of evidence derived from patients'
clinical information as they access their routine medical care. The value of real-world data …

Background The use of inhaled corticosteroids (ICS) in combination with bronchodilators in
patients with COPD has been shown to decrease the rate of disease exacerbations and to …

In 2020, chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death
in the United States excluding COVID-19, and its mortality burden has been rising since the …

Purpose Whether inhaled medications improve long‐term survival in Chronic Obstructive
Pulmonary Disease (COPD) is an open question. The purpose of this study is to assess the …

Chronic obstructive pulmonary disease (COPD) has a 3-year mortality rate up to 37%, 2–6
times higher than the general population. We present evidence supporting pharmacological …

Purpose To evaluate fluticasone propionate/formoterol (FP/FORM) in COPD. Patients and
methods COPD patients with forced expiratory volume in 1 s (FEV1)≤ 50% predicted and≥ …

Abstract The Global Initiative for Chronic Obstructive Lung Disease (GOLD), an international
committee of experts, has recently published its updated report on diagnosis and …

Chronic obstructive pulmonary disease (COPD) is a complex disease which consists in the
reduction of the airflow and leads to the disruption of the pulmonary tissue due to a chronic …

Background Randomized controlled trials at times investigate findings suggested by
observational studies. For example, the Towards a Revolution in COPD Health (TORCH) …